Company intelligence / Profile preview

American Lifelines

Ownership: Private
Development stage: Other

Overview

American Lifelines was a biotechnology company focused on the development of therapeutics aimed at extending human lifespan and addressing age-related decline. The company sought to identify and develop small molecule compounds that could modulate biological pathways associated with aging. Despite its ambitious goals in the longevity sector, the company did not progress significant candidates into advanced clinical trials and is currently inactive. Its primary focus remained on early-stage research into the mechanisms of senescence and metabolic health.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on American Lifelines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American Lifelines.

Explore the full profile